Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Desensitization via specific IgE modulation targets the immune system's allergic response, particularly by altering the production and function of allergen-specific Immunoglobulin E (IgE). This approach is central to allergen immunotherapy (AIT) and biologic treatments for allergic diseases. The goal is to reduce hypersensitivity reactions by modulating IgE levels, its receptor interactions, and downstream immune signaling.
Reduction/inhibition/modification of specific-IgEs' ability to trigger effector cell degranulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Desensitization via Specific IgE Modulation) (N/A).